The risk of sequelae due to pneumococcal meningitis in high-income countries: A systematic review and meta-analysis
Author:
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 61 (2) , 114-124
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Susceptibility of pneumococci causing meningitis in England and Wales to first-line antimicrobial agents, 2001–2004Journal of Antimicrobial Chemotherapy, 2005
- Incidence and outcome of pneumococcal meningitis in northern EnglandEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and WalesVaccine, 2004
- Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisationArchives of Disease in Childhood, 2004
- Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the NetherlandsClinical Therapeutics, 2003
- Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in SwitzerlandVaccine, 2003
- A Pharmacoeconomic Evaluation of 7‐Valent Pneumococcal Conjugate Vaccine in CanadaClinical Infectious Diseases, 2003
- Meningitis in infancy in England and Wales: follow up at age 5 yearsBMJ, 2001
- Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young ChildrenJAMA, 2000
- Outcomes of bacterial meningitis in childrenThe Pediatric Infectious Disease Journal, 1993